PharmaLogic and Ratio Therapeutics Expand Manufacturing Collaboration to Support Clinical Development of [Ac-225]RTX-2358

IDAHO FALLS, Idaho, May 29, 2026 /PRNewswire/ -- PharmaLogic Holdings Corp., ("PharmaLogic" or "the Company"), a leading contract development and manufacturing organization (CDMO) specialized in radiopharmaceuticals, today announced an expansion of its manufacturing partnership with Ratio...